advertisement
11.3.4 Betablocker (17)
Showing records 1 to 17
Display all abstracts in classification 11.3.4 Betablocker
Search within classification 11.3.4 Betablocker70792 Adherence to Fixed-Combination Versus Unfixed Travoprost 0.004%/Timolol 0.5% for Glaucoma or Ocular Hypertension: a Randomized Trial
Barnebey HS
American Journal of Ophthalmology 2017; 176: 61-69
70269 Extended wear therapeutic contact lens fabricated from timolol imprinted carboxymethyl chitosan-g-hydroxy ethyl methacrylate-g-poly acrylamide as a onetime medication for glaucoma
Anirudhan TS
European Journal of Pharmaceutics and Biopharmaceutics 2016; 109: 61-71
70528 Sustained Delivery of Timolol Maleate for Over 90 Days by Subconjunctival Injection
Lavik E
Journal of Ocular Pharmacology and Therapeutics 2016; 32: 642-649
70007 Cardiac safety of ophthalmic timolol
Mäenpää J
Expert Opinion on Drug Safety 2016; 15: 1549-1561
70052 Topical Beta-Blockers and Cardiovascular Mortality: Systematic Review and Meta-Analysis with Data from the EPIC-Norfolk Cohort Study
Pinnock C; Yip JL
Ophthalmic Epidemiology 2016; 23: 277-284
70528 Sustained Delivery of Timolol Maleate for Over 90 Days by Subconjunctival Injection
Kuehn MH
Journal of Ocular Pharmacology and Therapeutics 2016; 32: 642-649
70792 Adherence to Fixed-Combination Versus Unfixed Travoprost 0.004%/Timolol 0.5% for Glaucoma or Ocular Hypertension: a Randomized Trial
Robin AL
American Journal of Ophthalmology 2017; 176: 61-69
70007 Cardiac safety of ophthalmic timolol
Pelkonen O
Expert Opinion on Drug Safety 2016; 15: 1549-1561
70269 Extended wear therapeutic contact lens fabricated from timolol imprinted carboxymethyl chitosan-g-hydroxy ethyl methacrylate-g-poly acrylamide as a onetime medication for glaucoma
Nair AS
European Journal of Pharmaceutics and Biopharmaceutics 2016; 109: 61-71
70052 Topical Beta-Blockers and Cardiovascular Mortality: Systematic Review and Meta-Analysis with Data from the EPIC-Norfolk Cohort Study
Khawaja AP
Ophthalmic Epidemiology 2016; 23: 277-284
70269 Extended wear therapeutic contact lens fabricated from timolol imprinted carboxymethyl chitosan-g-hydroxy ethyl methacrylate-g-poly acrylamide as a onetime medication for glaucoma
Parvathy J
European Journal of Pharmaceutics and Biopharmaceutics 2016; 109: 61-71
70528 Sustained Delivery of Timolol Maleate for Over 90 Days by Subconjunctival Injection
Shoffstall AJ; Atkins K
Journal of Ocular Pharmacology and Therapeutics 2016; 32: 642-649
70052 Topical Beta-Blockers and Cardiovascular Mortality: Systematic Review and Meta-Analysis with Data from the EPIC-Norfolk Cohort Study
Luben R
Ophthalmic Epidemiology 2016; 23: 277-284
70528 Sustained Delivery of Timolol Maleate for Over 90 Days by Subconjunctival Injection
Dumitrescu AV
Journal of Ocular Pharmacology and Therapeutics 2016; 32: 642-649
70052 Topical Beta-Blockers and Cardiovascular Mortality: Systematic Review and Meta-Analysis with Data from the EPIC-Norfolk Cohort Study
Hayat S; Broadway DC
Ophthalmic Epidemiology 2016; 23: 277-284
70528 Sustained Delivery of Timolol Maleate for Over 90 Days by Subconjunctival Injection
Kwon YH
Journal of Ocular Pharmacology and Therapeutics 2016; 32: 642-649
70052 Topical Beta-Blockers and Cardiovascular Mortality: Systematic Review and Meta-Analysis with Data from the EPIC-Norfolk Cohort Study
Foster PJ; Khaw KT; Wareham N
Ophthalmic Epidemiology 2016; 23: 277-284